Home EsoBiotec

EsoBiotec

acquired
-
Developer of Immunocyte Therapy

Basic Information

EsoBiotec is a biotechnology company focused on in vivo cell therapy and also a developer of immunotherapy, aiming to make cancer treatment more accessible, effective, and affordable. The company develops cost-effective drugs and treatments, bringing in vivo cell engineering to patients, enabling them to access cancer treatment at a lower cost, thereby maximizing the accessibility of the human body's response to cancer.
EsoBiotec SA
--
15~50 people
January 01, 2020
--